Bioequivalence study of two formulations of paroxetine tablets in healthy male jordanian subjects applying lc/ms/ms

• In: Bioavailability/Bioequivalence - Posters
• At: Istanbul (Turkey) (2009)
• Type: Poster
• Poster code: BB-P-002
• By: AL-TAMIMI, Jaafar Jaber (Acdima BioCenter, Amman, Jordan)
• Co-author(s): Al Matarneh, Mohammad (Acdima BioCenter, Amman, Jordan)
  Muslih, Mohammad (Acdima BioCenter, Amman, Jordan)
  Berjawi, Mirna (Acdima BioCenter, Amman, Jordan)
  Al Nakhel, Claude (Algorithm, Beirut, Lebanon)
  Aki, Marleine (Algorithm, Beirut, Lebanon)
  
• Abstract:

  Objective: The bioequivalence of a single dose of Paxera tablets containing 20 mg paroxetine (Algorithm, Lebanon) as a test product in comparison to Seroxat® tablets containing 20 mg paroxetine (SmithKline Beecham Pharmaceuticals, England) as the reference product was studied. Material and methods: Both test and reference products were

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login